These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16845513)

  • 1. Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries.
    Laitinen I; Marjamäki P; Haaparanta M; Savisto N; Laine VJ; Soini SL; Wilson I; Leppänen P; Ylä-Herttuala S; Roivainen A; Knuuti J
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1461-7. PubMed ID: 16845513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
    Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques.
    Laitinen I; Marjamäki P; Någren K; Laine VJ; Wilson I; Leppänen P; Ylä-Herttuala S; Roivainen A; Knuuti J
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):73-80. PubMed ID: 18712383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
    Uotila S; Silvola JM; Saukko P; Nuutila P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J; Saraste A
    J Ultrasound Med; 2014 Nov; 33(11):1941-8. PubMed ID: 25336481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should vascular wall
    Lensen KDF; Voskuyl AE; Comans EFI; van der Laken CJ; Boellaard R; Smulders YM
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):545-551. PubMed ID: 31898005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.
    Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1011-5. PubMed ID: 21372297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
    Ben-Haim S; Kupzov E; Tamir A; Israel O
    J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
    Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
    Front Immunol; 2022; 13():821423. PubMed ID: 35145523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]FDG Accumulation in Early Coronary Atherosclerotic Lesions in Pigs.
    Tarkia M; Saraste A; Stark C; Vähäsilta T; Savunen T; Strandberg M; Saunavaara V; Tolvanen T; Teuho J; Teräs M; Metsälä O; Rinne P; Heinonen I; Savisto N; Pietilä M; Saukko P; Roivainen A; Knuuti J
    PLoS One; 2015; 10(6):e0131332. PubMed ID: 26120829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
    Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S
    J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of 11C-choline in mouse atherosclerotic plaques.
    Laitinen IE; Luoto P; Någren K; Marjamäki PM; Silvola JM; Hellberg S; Laine VJ; Ylä-Herttuala S; Knuuti J; Roivainen A
    J Nucl Med; 2010 May; 51(5):798-802. PubMed ID: 20395326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
    Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
    Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.
    Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
    J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression and 18FDG uptake in atherosclerotic carotid plaques.
    Pedersen SF; Graebe M; Fisker Hag AM; Højgaard L; Sillesen H; Kjaer A
    Nucl Med Commun; 2010 May; 31(5):423-9. PubMed ID: 20145577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with
    Hellberg S; Liljenbäck H; Eskola O; Morisson-Iveson V; Morrison M; Trigg W; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A
    Contrast Media Mol Imaging; 2018; 2018():9186902. PubMed ID: 29950954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
    Rominger A; Saam T; Wolpers S; Cyran CC; Schmidt M; Foerster S; Nikolaou K; Reiser MF; Bartenstein P; Hacker M
    J Nucl Med; 2009 Oct; 50(10):1611-20. PubMed ID: 19759117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18-kDa translocator protein ligand
    Hellberg S; Silvola JMU; Kiugel M; Liljenbäck H; Savisto N; Li XG; Thiele A; Lehmann L; Heinrich T; Vollmer S; Hakovirta H; Laine VJO; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    J Nucl Cardiol; 2017 Jun; 24(3):862-871. PubMed ID: 27225517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
    J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.